Data as of Q4 2025 (Dec 31, 2025)

Dauntless Investment Group, LLC

โ€ขCIK: 2044285โ€ขFiling: Q4 2025

**Dauntless Investment Group, LLC** manages $126M across a diversified portfolio of 66 positions. The fund exhibits significant overweighting in the high-yield sector, evidenced by the top holding in HYG at $35.8M. Further concentration is visible in XBI ($31.1M), suggesting a tactical focus on credit and cyclical value plays. Notable allocations also include substantial positions in technology and materials, such as NVDA ($7.0M) and GDX ($5.8M).

Total AUM
$27.2M
+ $98.7M in options
QoQ Performance
-28.7%
Positions
52
+ 12 options
Top 10 Concentration
78.0%
Latest Filing
Q4 2025

Top Holdings Allocation

HYG
XBI
NVDA
HYG28.4%
XBI24.7%
NVDA5.5%
GDX4.6%
FXI3.3%
ASHR3.1%
DE2.7%
JOE2.0%

๐Ÿ“ˆ Biggest Buys

HYGPUT
ISHARES TR
+21.2%
28.4% of portfolio
GDXPUT
VANECK ETF TRUST
NEW
4.6% of portfolio
NVDAPUT
NVIDIA CORPORATION
+125.3%
5.5% of portfolio
ASHRCALL
DBX ETF TR
+159.4%
3.1% of portfolio
CVNAPUT
CARVANA CO
NEW
1.6% of portfolio

๐Ÿ“‰ Biggest Sells

PLTRPUT
PALANTIR TECHNOLOGIES INC
-83.1%
1.1% of portfolio
AEM
AGNICO EAGLE MINES LTD
-98.8%
0.0% of portfolio
โ€”
OKYO PHARMA LTD
-80.5%
0.6% of portfolio
MPC
MARATHON PETE CORP
-69.4%
0.8% of portfolio
CRWVPUT
COREWEAVE INC
-42.5%
1.0% of portfolio

Sector Breakdown

Other88.5%
Technology5.5%
Industrial2.7%
Consumer2.0%
Energy1.3%

๐Ÿšช Exited Positionssold since Q3 2025

AAPL
APPLE INC
SOLD
$11.4M
XLY
SELECT SECTOR SPDR TR
SOLD
$7.3M
META
META PLATFORMS INC
SOLD
$6.8M
KO
COCA COLA CO
SOLD
$5.1M
LCTX
LINEAGE CELL THERAPEUTICS IN
SOLD
$2.7M
+20 more exited positions

Changes from Q3 2025

NEW26 new positions
โ†‘20 increased
โ†“16 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024